Get 30% off on all global market reports with code ONLINE30 – stay updated on tariff changes, macroeconomic trends, and more!
How Has the Angina Market Size Shifted in Recent Years?
Over the last few years, the angina market has seen substantial growth. It is expected to rise from $10.71 billion in 2024 to $11.36 billion in 2025, with a compound annual growth rate (CAGR) of 6.1%. This growth during the historical period is credited to the increased occurrence of coronary heart disease, a rise in vasodilators usage, a heightened prevalence of myocardial ischemia, enhanced diagnostic capacities, and an increased utilization of imaging techniques.
In the coming years, the angina market is predicted to experience substantial growth, reaching a value of $14.18 billion in 2029 with a compound annual growth rate (CAGR) of 5.7%. This surge during the forecast period is linked to the escalating occurrences of chronic angina pectoris, an upward trend in drug approvals and clinical research, a rising need for retail pharmacies, increased awareness of cardiovascular health, and an expanding demand for medicines. Major trends recognized for the forecast period encompass technological advancements in early diagnosis, progress in angioplasty and stenting procedures, emerging gene therapy methods, the growing need for coronary stents, and advances in treatments for coronary artery disease.
Claim Your Free Sample Report:
http://www.thebusinessresearchcompany.com/sample….p;type=smp
What Are the Key Drivers Fueling Growth in the Angina Market?
The continued increase in instances of coronary artery disease is anticipated to fuel the expansion of the angina market. Coronary artery disease (CAD), also referred to as coronary heart disease (CHD) or ischemic heart disease (IHD), is typified by the constriction or obstruction of the coronary arteries that supply the heart muscle with blood, oxygen, and essential nutrients. Such proliferation of CAD cases can be attributed to modifications in lifestyle, as well as factors related to the environment and genetics. Angina plays a pivotal role in both identifying and comprehending the extent of coronary artery disease, prompting medical examinations and diagnoses, aiding in risk assessment, directing treatment options, and shaping public health policies.
For example, the American Heart Association reported in January 2023, that between 2021 and 2022, the count of adults suffering from CAD in the U.S. surged from 18.2 million to roughly 19.3 million. Hence, the soaring counts of incidences related to coronary artery diseases end up acting as a catalyst for the angina market’s growth.
Which Key Segments Are Driving Growth in the Angina Market?
The anginamarket covered in this report is segmented –
1) By Type: Angina Pectoris; Unstable Angina; Prinzmetal Angina; Other Types
2) By Treatment: Lifestyle Changes; Medications; Angioplasty And Stenting; Coronary Bypass Surgery; Other Treatments
3) By Drug Class: Beta Blockers; Nitrates And Calcium Channel Blockers; Angiotensin-Converting Enzyme Inhibitors; Other Drug Classes
4) By Application: Clinics; Hospitals; Other Applications
Subsegments:
1) By Angina Pectoris: Stable Angina; Chronic Stable Angina; Effort-Induced Angina; Variant Or Microvascular Angina
2) By Unstable Angina: Acute Unstable Angina; Pre-Infarction Angina; Rest Angina
3) By Prinzmetal Angina: Vasospastic Angina; Coronary Artery Spasm-Induced Angina; Variant Angina
4) By Other Types: Nocturnal Angina; Post-Infarction Angina; Angina With Silent Myocardial Ischemia; Angina Due To Aortic Stenosis Or Valve Disease
Access the Full Report Today:
http://www.thebusinessresearchcompany.com/report/…ket-report
Which Emerging Trends Will Impact the Angina Market in the Forecast Period?
Leading organizations within the angina market are pioneering new drugs like metoprolol tartrate tablets, providing improved and specialized treatment for individuals with coronary artery disease (CAD) and related diseases. These tablets are a common medicine used typically to treat cardiovascular issues such as angina, hypertension, and heart failure. For instance, Zydus, a pharmaceutical company from India, received the final endorsement from the US Food and Drug Administration to produce and sell its generic form of Metoprolol Tartrate Tablets USP at dosages of 25 mg, 50 mg, and 100 mg in April 2023. Metoprolol, a beta blocker, is used for treating a range of cardiovascular problems including hypertension and angina, as well as enhancing survival rates post-heart attack.
Which Geographies Are Leading the Expansion of the Angina Market?
North America was the largest region in the angina market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get a Customized Version of the Report:
http://www.thebusinessresearchcompany.com/customi…p;type=smp
Who Are the Top Companies Dominating the Angina Market in 2025?
Major companies operating in the angina market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co Inc., Bayer AG, Sanofi S.A., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott laboratories, GlaxoSmithKline Plc, Eli Lilly and Company, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd, Amgen Inc., Dr. Reddy’s Laboratories, ViroMed Co. Ltd., Lee’s Pharmaceutical Holdings, Kuhnil Pharmaceutical, LegoChem Biosciences, Axus Cardium Pharmaceuticals, Juventas Therapeutics, Milestone Pharmaceuticals
Access the Complete Report:
http://www.thebusinessresearchcompany.com/purchas…x?id=16337
How Our Market Research Reports Help Maximize ROI Across Industries:
* Identify High-Growth Opportunities: Pinpoint emerging trends, untapped segments, and regional hotspots that align with your strategic goals.
* Reduce Investment Risk: Make data-driven decisions with confidence by understanding market dynamics, key drivers, and competitive threats.
* Optimize Strategic Planning: Align your product development, marketing, and expansion plans with industry forecasts and customer behaviour insights.
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
News From
The Business Research Company …
Category: Industry Reports & Market Analysis Profile: The Business Research Company is a leading market research and consulting services provider. It offers over 9,500 market reports across 27 industries in 60+ geographies, providing detailed insights and forecasts. Its customised research solutions support companies in making critical decisions, while its continuous research service enhances organizational capabilities. The flagship Global Market Model database provides comprehensive market intelligence with 1,500,000 datasets covering 8,000+ mark …
This email address is being protected from spambots. You need JavaScript enabled to view it.
